AnPing Chen

Company: Cytovia Therapeutics

Job title: Associate Director

Seminars:

Panel Discussion: Benchmarking Safety Considerations During Gene Editing Protocols to Ease Regulatory Burdens 12:20 pm

Balancing therapeutic potential of immortalized cells with safety considerations Discussing best practices for combatting offsite mutations to reduce adverse effects Monitoring cell behavior to prevent product contaminationRead more

day: Track A AM

Improved Anti-Tumor Immune Function of TGFβR2 Knock Out and IL-15 Knock In iPSC-Derived NK (iNK) Cells by TALEN® Editing 11:40 am

The off-target effect of TALEN pairs were detected, and these TALEN®-edited iPSCs kept their pluripotency, exhibited normal morphology and karyotype. Engineered iNK cells with IL-15 KI and TGFβR2 KO consist of a homogeneous population of CD56+ NK cells (>99%) with the expression of several typical NK markers. The iNK cells with TGFβR2 KO are resistant…Read more

day: Track A AM